ALMR

Alamar Biosciences, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$25.27

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %3.5 / %30

Non-compliant assets / Total market cap %6.2 / %30

Non-compliant income / Total income %4.2 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.